Speakers

A B C D F G H J K L Ł M N O P R S Ś T W Z
Piotr Rutkowski

Piotr Rutkowski

Piotr Rutkowski is Professor of Surgical Oncology at the Maria Sklodowska-Curie Institute – Oncology Center in Warsaw, Poland.

Dr Rutkowski is the current Head of the Department of Soft Tissue/Bone Sarcoma and Melanoma, the Plenipotentiary Director of Institute for Clinical Trials at the Maria Sklodowska-Curie Institute – Oncology Center as well as the VicePresident of Scientific Council of Maria Sklodowska-Curie Institute – Oncology Center. He has participated in several investigator-driven trials in melanoma and sarcoma. He is also Coordinator of the Polish Clinical GIST Registry, and a reviewer for several international scientific journals, as well as a member of the Editorial Board of Annals of Surgical Oncology and European Journal of Surgical Oncology.

 

Dr Rutkowski is an active member of the EORTC Melanoma Group; EORTC Soft Tissue and Bone Sarcoma Group, where he chaired the Local Treatment Subcommittee and the Membership Committee of the EORTC Board. He is also Chair of Melanoma Track for ESMO Congress 2019. He is a member of several Polish and international scientific societies (Secretary and Past-President of Polish Society Surgical Oncology and Ex-member of the Board of Directors of the Connective Tissue Oncology Society). He has been Principal Investigator of several clinical trials in the field of cutaneous malignancies and sarcoma. Dr Rutkowski has authored or co-authored over 140 scientific papers in Polish and international journals (with an impact factor of above 4000, index-H: 46, citation index >12000), and is co-author of national and international recommendations for sarcoma and melanoma. He is working very closely with national patient advocacy groups for GIST/sarcoma and melanoma and is Chairman of the Melanoma Academy in Poland, coordinator of Polish GIST Registry.

Participates in the sessions:

  • Onkologia – wybrane zagadnienia terapeutyczne i organizacyjne

    MORE SPEAKERS
     

    Onkologia – wybrane zagadnienia terapeutyczne i organizacyjne

    • Ustawa o Narodowej Strategii Onkologicznej – czy uporządkuje system opieki onkologicznej w Polsce?
    • Podsumowanie dotychczasowego przebiegu pilotażu Krajowej Sieci Onkologicznej – opinie lekarzy, pacjentów, menedżerów zarządzających ośrodkami onkologicznymi
    • Deficyty kadrowe w polskiej onkologii – skala problemu i możliwości jego rozwiązania
    • Narodowy Program Zwalczania Chorób Nowotworowych – bilans wydatków i efektów
    • Nowe opcje terapeutyczne w wybranych chorobach nowotworowych – ich finansowanie i dostępność w Polsce
BACK